Back

Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors

5 April 2025 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Risk prediction: novel markers Scores EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mrs Mari Nordboe Gynnild

St. Olav University Hospital, Trondheim (Norway)

4 More presentations in this session

Presentation thumbnail
The prognostic value of peak postoperative high-sensitive troponin T in patients undergoing elective cardiac surgery and rehabilitation
Doctor F. Robotti (Milan, IT)
Abstract Slides
Presentation thumbnail
The use of ophthalmic fundus imaging to predict cardiovascular risk factors: a systematic review
Doctor A. Abo Dan (Laval, CA)
Abstract Slides
Presentation thumbnail
Prevalence and predictors of elevated cardiovascular risk in patients with subclinical hypothyroidism
Doctor A. Albulushi (Muscat, OM)
Abstract Slides
Presentation thumbnail
Time to change the electrocardiography (ECG) indices of left ventricular hypertrophy: the Bialystok PLUS and SHIP-TREND population-based studies
Doctor M. Chlabicz (Bialystok, PL)
Abstract Slides

Access the full session

Session thumbnail
Risk prediction: novel markers

The Event

Event poster

ESC Preventive Cardiology 2025

5 April 2025 12:00 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
thumbnail
Practice Tools
Risk Scores in Secondary Cardiovascular Prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources